Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (26604)	4/8/2008 10:36:07 PM
From: Robohogs	Read Replies (1) \| Respond to of 52153

I have to say I was surprised when I was reading through a report on these types of loans. I had expected a 16% risk capital weighting or something similar to normal loans but for some reason, it was listed as 100% capital charge. These are the old HLTs (I think that was the old nomenclature) by the way. I also assume the banks' models get away with charging less capital using historical databases (which is allowed for the large banks under basel II). Jon